🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)

Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL NCT06874946Phase 1, Phase 21 site📍 Beijing Peking University People's Hospital · Tests: CD5-targeted CAR-T cells A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL NCT06855823Phase 1, Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Golicitinib combined with Pomadomide Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma NCT06151106Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Chidamide combined with Duvillisib A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19) NCT07234162Phase 351 sites📍 Hefei📍 Hefei📍 Beijing Dizal Pharmaceuticals · Tests: Golidocitinib, Chidamide, Gemcitabine Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL) NCT05833724Phase 26 sites📍 Kaohsiung City📍 Kaohsiung City📍 New Taipei City Great Novel Therapeutics Biotech & Medicals Corporation · Tests: Chidamide Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma NCT06909877Phase 1, Phase 21 site📍 Chengdu Haihe Biopharma Co., Ltd. · Tests: HH2853 Tablets CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas NCT07022964Phase 1, Phase 23 sites📍 Beijing📍 Shanghai📍 Shanghai Beijing GoBroad Hospital · Tests: CD5 CAR-T cells infusion A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas NCT07018752Phase 1, Phase 220 sites📍 Caen📍 Clermont-Ferrand📍 Créteil The Lymphoma Academic Research Organisation · Tests: roginolisib, golcadomide, azacitidine CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas NCT06925464Phase 1, Phase 24 sites📍 Beijing📍 Zhanjiang📍 Shanghai Beijing GoBroad Hospital · Tests: CD7 CAR-T cells infusion Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL NCT07372352Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Zeprumetostat, Azacitidine (AZA), Mitoxantrone Hydrochloride Liposome To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL NCT07143929Phase 11 site📍 Beijing Peking University People's Hospital · Tests: CAR-T
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy